Compare Nutanix Inc (NTNX) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutanix Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Nutanix Inc trades at $72.61 (market cap $19.87B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.27 (market cap $2.28B). The key difference: Nutanix Inc is far larger — about 8.7× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Nutanix Inc is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| NTNX | SLS | |
|---|---|---|
Market Cap | $19.87B | $2.28B |
Volume | 2,953,276 | 3,128,960 |
Sector | Technology | Health |
52-Week High | $73.42 | $15.46 |
52-Week Low | $34.41 | $1.39 |
Typical Hold Time | 17 Days | — |
Enterprise Value | $19.02B | $2.15B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nutanix (NTNX) trades at $73.42, up slightly by 0.01% on the day. The stock exhibits a bullish technical trend with strong analyst support, including 20 buy ratings and a consensus price target of $76.11. Recent quarterly earnings have consistently beaten estimates, with Q2 2026 EPS of $0.60 surpassing the $0.49 expectation. The company's revenue grew to $2.54 billion in 2025, with a net income margin of 52.81%, though the ROE remains negative at -395.76%.
The outlook for NTNX is positive, driven by strong earnings performance and recognition as a leader in Gartner Magic Quadrant reports. Key opportunities include growth in external storage and AI initiatives. Risks involve high valuation multiples like EV/EBITDA of 46.43 and competitive pressures in the IT services sector. The stock's current price near the consensus target suggests limited upside unless future earnings exceed expectations.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
